Comparative Efficacy of Colonoscope Distal Attachment Devices in Increasing Rates of Adenoma Detection: A Network Meta-analysis

医学 结肠镜检查 荟萃分析 随机对照试验 泻药 梅德林 腺瘤 相对风险 置信区间 内科学 外科 结直肠癌 癌症 政治学 法学
作者
Antonio Facciorusso,Valentina Del Prete,Rosario Vincenzo Buccino,Nicola Della Valle,Maurizio Cosimo Nacchiero,Fabio Monica,Renato Cannizzaro,Nicola Muscatiello
出处
期刊:Clinical Gastroenterology and Hepatology [Elsevier BV]
卷期号:16 (8): 1209-1219.e9 被引量:64
标识
DOI:10.1016/j.cgh.2017.11.007
摘要

Background & AimsSeveral add-on devices have been developed to increase rates of colon adenoma detection (ADR). We assessed their overall and comparative efficacy, and estimated absolute magnitude of benefit through a network meta-analysis.MethodsWe searched the PubMed/Medline and Embase database through March 2017 and identified 25 randomized controlled trials (comprising 16,103 patients) that compared the efficacy of add-on devices (cap; Endocuff; Arc Medical Design Ltd, Leeds, UK, and Endorings; Us Endoscopy, Mentor, OH) with each other or with standard colonoscopy. The primary outcome was ADR; secondary outcomes included rate of polyp detection, and rate of and time to cecal intubation. We performed pairwise and network meta-analyses, and appraised quality of evidence using Grading of Recommendations Assessment, Development and Evaluation. We estimated the magnitude of increase in ADR by low-performing endoscopists (baseline ADR, 10%) and high-performing endoscopists (baseline ADR, 40%) with use of these devices.ResultsOverall, distal attachment devices increased ADR compared with standard colonoscopy (relative risk [RR], 1.13; 95% CI, 1.03–1.23; low-quality evidence), with potential absolute increases in ADR to 11.3% for low-performing endoscopists and to 45.2% for high-performing endoscopists. In a comparative evaluation, we found low-quality evidence that Endocuff increases ADR compared with standard colonoscopy (RR, 1.21; 95% CI, 1.03–1.41), with anticipated increases in ADR to 12% for low-performing endoscopists and to 48% for high-performing endoscopists. We found very low quality evidence to support the use of Endorings (RR, 1.70; 95% CI, 0.86–3.36) or caps (RR, 1.07; 95% CI, 0.96–1.19) vs standard colonoscopy for increasing ADR. The benefit of one distal attachment device over another was uncertain due to very low quality evidence.ConclusionsBased on network meta-analysis, we anticipate only modest improvement in ADRs with use of distal attachment devices, especially in low-performing endoscopists. Several add-on devices have been developed to increase rates of colon adenoma detection (ADR). We assessed their overall and comparative efficacy, and estimated absolute magnitude of benefit through a network meta-analysis. We searched the PubMed/Medline and Embase database through March 2017 and identified 25 randomized controlled trials (comprising 16,103 patients) that compared the efficacy of add-on devices (cap; Endocuff; Arc Medical Design Ltd, Leeds, UK, and Endorings; Us Endoscopy, Mentor, OH) with each other or with standard colonoscopy. The primary outcome was ADR; secondary outcomes included rate of polyp detection, and rate of and time to cecal intubation. We performed pairwise and network meta-analyses, and appraised quality of evidence using Grading of Recommendations Assessment, Development and Evaluation. We estimated the magnitude of increase in ADR by low-performing endoscopists (baseline ADR, 10%) and high-performing endoscopists (baseline ADR, 40%) with use of these devices. Overall, distal attachment devices increased ADR compared with standard colonoscopy (relative risk [RR], 1.13; 95% CI, 1.03–1.23; low-quality evidence), with potential absolute increases in ADR to 11.3% for low-performing endoscopists and to 45.2% for high-performing endoscopists. In a comparative evaluation, we found low-quality evidence that Endocuff increases ADR compared with standard colonoscopy (RR, 1.21; 95% CI, 1.03–1.41), with anticipated increases in ADR to 12% for low-performing endoscopists and to 48% for high-performing endoscopists. We found very low quality evidence to support the use of Endorings (RR, 1.70; 95% CI, 0.86–3.36) or caps (RR, 1.07; 95% CI, 0.96–1.19) vs standard colonoscopy for increasing ADR. The benefit of one distal attachment device over another was uncertain due to very low quality evidence. Based on network meta-analysis, we anticipate only modest improvement in ADRs with use of distal attachment devices, especially in low-performing endoscopists.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
天天快乐应助KEFE采纳,获得10
1秒前
李健应助XxxxxtPuCO采纳,获得10
3秒前
科研通AI6.2应助Zyra采纳,获得10
3秒前
Viper完成签到 ,获得积分10
3秒前
温洋完成签到,获得积分10
3秒前
4秒前
4秒前
源宝完成签到 ,获得积分10
5秒前
1234完成签到,获得积分10
6秒前
6秒前
悦耳忆曼完成签到,获得积分10
7秒前
pamela完成签到 ,获得积分10
8秒前
9秒前
姜灭绝发布了新的文献求助10
10秒前
儒雅的新儿完成签到,获得积分10
11秒前
湛湛发布了新的文献求助10
13秒前
linan发布了新的文献求助10
15秒前
Orange应助mbf采纳,获得10
16秒前
May0791发布了新的文献求助10
18秒前
可爱的函函应助fyl采纳,获得10
19秒前
刘荣鑫完成签到 ,获得积分10
19秒前
chenhui完成签到,获得积分10
19秒前
豪123456完成签到,获得积分10
20秒前
爆米花应助11采纳,获得10
20秒前
fangmuyi完成签到,获得积分10
22秒前
xiaolizi发布了新的文献求助30
22秒前
Akim应助Zyra采纳,获得10
23秒前
linade发布了新的文献求助10
25秒前
搜集达人应助湛湛采纳,获得10
26秒前
赘婿应助LJL采纳,获得10
26秒前
sjfh发布了新的文献求助10
27秒前
27秒前
呵呵完成签到,获得积分10
27秒前
岁岁菌完成签到,获得积分10
27秒前
科研通AI2S应助renhu采纳,获得30
28秒前
行呀完成签到,获得积分10
30秒前
淇淇发布了新的文献求助10
31秒前
欢喜的诗珊完成签到,获得积分10
37秒前
星辰大海应助LJL采纳,获得10
38秒前
39秒前
高分求助中
Markov Chain Monte Carlo 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Common Foundations of American and East Asian Modernisation: From Alexander Hamilton to Junichero Koizumi 1000
Weaponeering: An Introduction Fourth Edition, Volume 1 1000
Advanced Weaponeering Fourth Edition, Volume 2 1000
Evidence Summary. Injection (subcutaneous):op- timal administration 1000
悉尼大学博士学位论文,题目:Modelling and testing of one-sided stitched laminated composites. 作者:Kristopher P. Plain 700
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7499425
求助须知:如何正确求助?哪些是违规求助? 9090152
关于积分的说明 19391193
捐赠科研通 7109607
什么是DOI,文献DOI怎么找? 3250583
关于科研通互助平台的介绍 2420001
邀请新用户注册赠送积分活动 2236456